UBS AM’s Aktis Oncology AKTS Stock Holding History
Bought
Maintained
Sold
Other funds holding AKTS
UBS AM's AKTS Position: Q3 2026 in Review
UBS AM opened a new position in Aktis Oncology (AKTS) in Q3 2026: 331 shares worth $6.44K. The stake represents ﹤0.01% of the portfolio and ranks #3873 among its holdings.
105 funds tracked by Wall St. Rank hold AKTS as of Q3 2026.
- UBS AM held 331 shares of Aktis Oncology worth $6.44K as of Q3 2026.
- Aktis Oncology was a new UBS AM position in Q3 2026.
- Aktis Oncology made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #3873 holding.
- 105 funds tracked by Wall St. Rank held Aktis Oncology as of Q3 2026.
Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.